James H Mackaness Soleno Therapeutics Inc (SLNO) insider trading activity

SLNO Quotes by TradingView

James H Mackaness is CHIEF FINANCIAL OFFICER of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 125,798 shares of SLNO, which is worth approximately $5.8 Million. The most recent transaction as insider was on Jan 21, 2025, when has been sold 14,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
5.56% 3M change
84.65% 12M change
Total Value Held $5.8 Million

James H Mackaness Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
BUY
Grant, award, or other acquisition
-
14,500 Added 10.34%
125,798 Common Stock
Jan 03 2025
SELL
Open market or private sale
$175,068 $46.18 p/Share
3,791 Reduced 3.29%
111,298 Common Stock
Jan 02 2025
SELL
Open market or private sale
$186,348 $45.64 p/Share
4,083 Reduced 3.43%
115,089 Common Stock
Oct 01 2024
SELL
Open market or private sale
$402,234 $49.8 p/Share
8,077 Reduced 6.35%
119,172 Common Stock
Aug 29 2024
SELL
Open market or private sale
$326,325 $47.5 p/Share
6,870 Reduced 5.12%
127,249 Common Stock
Aug 28 2024
SELL
Open market or private sale
$317,130 $47.61 p/Share
6,661 Reduced 4.73%
134,119 Common Stock
Aug 06 2024
SELL
Open market or private sale
$365,460 $44.93 p/Share
8,134 Reduced 5.46%
140,780 Common Stock
Aug 05 2024
SELL
Open market or private sale
$313,752 $45.81 p/Share
6,849 Reduced 4.4%
148,914 Common Stock
Jul 17 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 39.1%
155,763 Common Stock
Jul 01 2024
SELL
Open market or private sale
$297,881 $41.43 p/Share
7,190 Reduced 11.42%
55,763 Common Stock
Apr 01 2024
SELL
Open market or private sale
$214,193 $41.39 p/Share
5,175 Reduced 7.6%
62,953 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
56,000 Added 45.11%
68,128 Common Stock
Dec 11 2023
SELL
Open market or private sale
$1,177,147 $36.24 p/Share
32,482 Reduced 72.81%
12,128 Common Stock
Dec 11 2023
BUY
Exercise of conversion of derivative security
$39,000 $2.6 p/Share
15,000 Added 25.16%
44,610 Common Stock
Nov 30 2023
SELL
Open market or private sale
$119,928 $28.65 p/Share
4,186 Reduced 16.42%
21,303 Common Stock
Nov 29 2023
SELL
Open market or private sale
$117,053 $27.85 p/Share
4,203 Reduced 14.16%
25,489 Common Stock
Nov 28 2023
SELL
Open market or private sale
$105,908 $27.31 p/Share
3,878 Reduced 11.55%
29,692 Common Stock
Oct 02 2023
BUY
Exercise of conversion of derivative security
$24,262 $2.92 p/Share
8,309 Added 16.56%
41,879 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
29,084 Added 46.42%
33,570 Common Stock
Mar 31 2022
BUY
Open market or private purchase
-
40,000 Added 37.28%
67,295 Common Stock
Sep 13 2021
BUY
Open market or private purchase
$9,999 $0.89 p/Share
11,235 Added 29.16%
27,295 Common Stock
Jun 26 2020
BUY
Open market or private purchase
$9,999 $1.65 p/Share
6,060 Added 27.4%
16,060 Common Stock
JHM

James H Mackaness

CHIEF FINANCIAL OFFICER
Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLNO